Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
152.80    -0.20 (-0.13%)
Bid:
153.20
Ask:
153.60
Spread: 0.40 (0.261%)
Market Cap: £874.50m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Trading Update

18 Jan 2022 07:00

RNS Number : 7365Y
Elementis PLC
18 January 2022
 

Elementis plc

Trading Update

FY 21 adjusted operating profit modestly ahead of expectations

Leverage reduction on track

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues a trading update for the three months and year ended 31 December 2021.

Business performance

 

The Group has delivered a good fourth quarter performance, with double-digit year-on-year underlying revenue growth, agile supply chain management and self-help actions. As a result, adjusted operating profit for 2021 is expected to be in the range of $105-107m, modestly ahead of expectations*.

 

· Coatings performed well in Q4, and ahead of the prior year. As a result of pricing actions and volume growth, the business will deliver improved operating margins versus 2020.

 

· Personal Care performance in Q4 improved on the prior year. Demand continued to recover in cosmetics, as social and travel restrictions begin to ease, albeit still at levels below 2019.

 

· Talc performance in Q4 was below prior year as semi-conductor supply shortages continued to reduce automotive related demand.

· Chromium performance improved on the prior year as strong industrial demand was supported by improved pricing trends as global industry capacity utilisation increased.

 

In the fourth quarter we have continued to successfully deliver our Innovation, Growth and Efficiency strategy. For the full year 2021 we launched over 20 new products, won more than $35m of new business and delivered $10m of in year cost savings.

Balance Sheet

 

Net debt (excluding lease liabilities) at the end of 2021 is anticipated to be approximately $400m, representing a leverage ratio of 2.6x net debt to EBITDA**, and a significant reduction compared to 3.2x reported at the 31 December 2020.

 

Full 2021 results will be released on 3 March 2022 at 7am (UK) and will be available via the Elementis Plc website.

 

 

Enquiries

Elementis plc

James Curran, Investor Relations Tel: 020 7067 2994

 

Tulchan

Martin Robinson Tel: 020 7353 4200

Olivia Peters

 

* Based on company compiled consensus, the Board believes the average market forecast for 2021 adjusted operating profit to be $104m.

 

**Excluding IFRS 16 impact

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUPUGUPPGBM
Date   Source Headline
12th Nov 20209:39 amRNSResponse to Minerals Technologies Inc announcement
12th Nov 20207:51 amRNSStatement re Possible Offer
9th Nov 20204:55 pmRNSHolding(s) in Company
28th Oct 20207:00 amRNSQ3 Trading Update
26th Oct 20207:00 amRNSUpdate on 2020 AGM resolution vote
16th Oct 20207:00 amRNSDirectorate Change
17th Sep 202012:40 pmRNSDirector/PDMR Shareholding
7th Sep 20207:00 amRNSCovenant update
1st Sep 20202:22 pmRNSBlock listing Interim Review
28th Jul 20207:00 amRNSHalf-year Report
8th Jun 20204:28 pmRNSHolding(s) in Company
15th May 20201:08 pmRNSHolding(s) in Company
1st May 20209:56 amRNSTotal Voting Rights
29th Apr 202011:02 amRNSDirector Declaration
29th Apr 202010:49 amRNSResult of AGM
29th Apr 20207:00 amRNSAGM Trading Statement
28th Apr 202012:06 pmRNSDisclosure of rights attached to equity shares
21st Apr 20207:00 amRNSAGM update
8th Apr 202011:50 amRNSDirector/PDMR Shareholding
2nd Apr 20202:51 pmRNSHolding(s) in Company
1st Apr 20208:13 amRNSDirector Declaration
25th Mar 20204:04 pmRNSAnnual Financial Report
25th Mar 202010:19 amRNSHolding(s) in Company
24th Mar 20209:02 amRNSHolding(s) in Company
23rd Mar 20205:25 pmRNSHolding(s) in Company
20th Mar 20205:28 pmPRNDirector/PDMR Shareholding
20th Mar 20205:07 pmRNSDirector/PDMR Shareholding
20th Mar 20205:06 pmRNSDirector/PDMR Shareholding
20th Mar 202010:44 amRNSHolding(s) in Company
19th Mar 20204:28 pmRNSDirector/PDMR Shareholding
19th Mar 20204:25 pmRNSDirector/PDMR Shareholding
19th Mar 20204:24 pmRNSDirector/PDMR Shareholding
19th Mar 20207:00 amPRNCOVID-19 update
18th Mar 20203:14 pmRNSAdditional Listing
17th Mar 202010:25 amRNSDirector/PDMR Shareholding
12th Mar 202010:36 amRNSDirector/PDMR Shareholding
10th Mar 20202:02 pmRNSDirector/PDMR Shareholding
9th Mar 202010:57 amRNSDirector/PDMR Shareholding
6th Mar 20202:36 pmRNSDirector/PDMR Shareholding
6th Mar 20202:35 pmRNSDirector/PDMR Shareholding
5th Mar 20201:41 pmRNSDirector/PDMR Shareholding
4th Mar 20207:00 amRNS2019 Preliminary Results Announcement
2nd Mar 20203:46 pmRNSBlock listing Interim Review
2nd Mar 202011:22 amPRNTotal Voting Rights
4th Feb 20207:00 amRNSDirectorate Change
21st Jan 20208:46 amPRNDirector Declaration
20th Jan 202010:54 amPRNHolding(s) in Company
14th Jan 20207:00 amRNSTrading update
6th Jan 202010:09 amPRNHolding(s) in Company
2nd Jan 202011:12 amPRNTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.